Side-by-side comparison of AI visibility scores, market position, and capabilities
Commercial P&C and group benefits insurer with $24.7B FY2024 revenue; top-3 workers' comp writer; life/mutual funds sold 2018-2022 for strategic focus; hard market beneficiary in commercial lines.
The Hartford Financial Services Group is a leading provider of property and casualty insurance, group benefits, and mutual funds, founded in 1810 in Hartford, Connecticut and still headquartered there, trading on NYSE (HIG). For FY2024, The Hartford generated approximately $24.7 billion in total revenues under CEO Christopher Swift, who has led the company since 2014 and executed a strategic sharpening around commercial P&C insurance and employee benefits following the sale of the company's life insurance operations to Talcott Resolution in 2018 and the mutual funds business to Lexington Partners in 2022. The company's Commercial Lines segment—serving small, mid, and large commercial customers across workers' compensation, commercial auto, general liability, property, and specialty—is the revenue and earnings anchor.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.